MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from public
offerings
$6,090K
Proceeds from warrant
inducement financing
$4,136K
Proceeds from exercise of
pre-funded warrants
$2K
Net cash provided by
financing activities
$9,480K
Canceled cashflow
$748K
Net increase
(decrease) in cash and...
$5,215K
Canceled cashflow
$4,265K
Repayment of principal on
related party term notes...
$375K
Payment of financing
costs
$344K
Repayment of financing
lease obligations
$29K
Stock-based compensation
$529K
Depreciation and
amortization expense
$427K
Accrued expenses and
other current...
$264K
Prepaid expenses and
other current assets
-$118K
Change in fair value of
other liabilities and...
$100K
Net cash used in
operating activities
-$4,238K
Net cash used in
investing activities
-$27K
Canceled cashflow
$1,438K
Net loss
-$5,181K
Purchases of machinery and
equipment
$27K
Operating lease right of
use liability
-$304K
Accounts payable
-$191K
Back
Back
Cash Flow
source: myfinsight.com
Calidi Biotherapeutics, Inc. (CLDWW)
Calidi Biotherapeutics, Inc. (CLDWW)